Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Abbott Laboratories (ABT)

Abbott Laboratories (ABT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 210,646,944
  • Shares Outstanding, K 1,738,872
  • Annual Sales, $ 41,950 M
  • Annual Income, $ 13,402 M
  • EBIT $ 9,438 M
  • EBITDA $ 12,656 M
  • 60-Month Beta 0.72
  • Price/Sales 4.83
  • Price/Cash Flow 18.50
  • Price/Book 4.13

Options Overview Details

View History
  • Implied Volatility 24.48% (-1.01%)
  • Historical Volatility 16.53%
  • IV Percentile 73%
  • IV Rank 30.76%
  • IV High 42.50% on 04/07/25
  • IV Low 16.47% on 01/24/25
  • Expected Move (DTE 2) 3.80 (3.11%)
  • Put/Call Vol Ratio 1.57
  • Today's Volume 28,526
  • Volume Avg (30-Day) 14,133
  • Put/Call OI Ratio 1.13
  • Today's Open Interest 134,691
  • Open Int (30-Day) 192,090
  • Expected Range 118.31 to 125.91

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 28 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate 1.50
  • Number of Estimates 10
  • High Estimate 1.51
  • Low Estimate 1.49
  • Prior Year 1.34
  • Growth Rate Est. (year over year) +11.94%

Price Performance

See More
Period Period Low Period High Performance
1-Month
120.25 +1.34%
on 01/20/26
129.46 -5.87%
on 01/06/26
-3.59 (-2.86%)
since 12/19/25
3-Month
120.25 +1.34%
on 01/20/26
132.02 -7.70%
on 11/18/25
-5.68 (-4.45%)
since 10/21/25
52-Week
113.50 +7.37%
on 01/22/25
141.23 -13.72%
on 03/04/25
+5.07 (+4.34%)
since 01/21/25

Most Recent Stories

More News
Abbott Laboratories (ABT) Q4 Earnings Report Preview: What To Look For

Abbott Laboratories (ABT) Q4 Earnings Report Preview: What To Look For

ABT : 120.94 (-0.17%)
What To Expect From Abbott Laboratories’s (ABT) Q4 Earnings

What To Expect From Abbott Laboratories’s (ABT) Q4 Earnings

ABT : 120.94 (-0.17%)
2 Healthcare Names That Could Get a Big Boost From Earnings

Both Abbott Laboratories and Intuitive Surgical report fourth-quarter results in late January—and both companies offer investors multiple reasons to be bullish.

ABT : 120.94 (-0.17%)
ISRG : 523.09 (-0.82%)
Abbott receives CE Mark for the TactiFlexâ„¢ Duo Ablation Catheter to treat patients with abnormal heart rhythms

ABBOTT PARK, Ill. , Jan. 20, 2026 /PRNewswire/ -- Abbott (NYSE: ABT) today announced it has received CE Mark in Europe for the TactiFlex™ Duo Ablation Catheter, Sensor Enabled™ to treat patients...

ABT : 120.94 (-0.17%)
Stock Index Futures Plunge After Trump’s Tariff Threats on Europe Over Greenland

March S&P 500 E-Mini futures (ESH26) are down -1.58%, and March Nasdaq 100 E-Mini futures (NQH26) are down -1.95% this morning, pointing to a sharply lower open on Wall Street as sentiment took a hit after...

MSTR : 163.61 (+2.11%)
GOOGL : 328.34 (+1.97%)
JNJ : 218.41 (+0.09%)
COIN : 227.18 (-0.24%)
CIEN : 231.61 (-3.98%)
ABT : 120.94 (-0.17%)
RAPT : 57.61 (+0.07%)
TLN : 374.36 (+4.96%)
NQH26 : 25,478.25 (+1.39%)
AMD : 249.32 (+7.50%)
BKW.Z.EB : 157.600 (+1.35%)
GE : 320.02 (+2.46%)
Inflation Figures Highlight Week in Toronto

Monday U.S. Markets are closed for Martin Luther King Day. Canada Consumer Price Index ...

NFLX : 85.46 (-2.06%)
ABT : 120.94 (-0.17%)
IBN : 29.32 (-0.61%)
USB : 55.59 (+2.23%)
JNJ : 218.41 (+0.09%)
PG : 145.76 (-0.84%)
SLB : 48.38 (+4.16%)
SCHW : 101.74 (+0.74%)
PLD : 131.08 (+0.21%)
MMM : 155.47 (-0.42%)
GE : 320.02 (+2.46%)
NEE : 83.64 (+0.16%)
Exact Sciences Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Exact Sciences Corporation - EXAS

NEW YORK  and NEW ORLEANS , Jan. 16, 2026 /PRNewswire/ -- Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti , LLC ("KSF") are investigating...

ABT : 120.94 (-0.17%)
EXAS : 102.46 (+0.11%)
1 Healthcare Stock to Consider Right Now and 2 We Find Risky

1 Healthcare Stock to Consider Right Now and 2 We Find Risky

TXG : 22.66 (+2.77%)
ABT : 120.94 (-0.17%)
OCUL : 11.42 (-0.26%)
Here's What to Expect From Vertex Pharmaceuticals' Next Earnings Report

Vertex Pharmaceuticals is scheduled to post its fourth-quarter results soon, and analysts project a double-digit earnings growth

ABT : 120.94 (-0.17%)
XLV : 158.28 (+1.85%)
$SPX : 6,881.55 (+1.25%)
VRTX : 461.41 (+4.37%)
Zimmer Biomet’s Q3 2025 Earnings: What to Expect

Zimmer Biomet is poised to report its fourth-quarter results in the near future, and Wall Street anticipates a measured, single-digit increase in earnings.

ZBH : 86.74 (-0.07%)
ABT : 120.94 (-0.17%)
XLV : 158.28 (+1.85%)
$SPX : 6,881.55 (+1.25%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Abbott Labs discovers, develops, manufactures & sells a diversified line of health care products. Established Pharmaceuticals Division includes branded generics business in the emerging markets. Medical Devices unit includes the diabetes care, vision care & vascular businesses. Diagnostics unit manufactures...

See More

Key Turning Points

3rd Resistance Point 122.93
2nd Resistance Point 122.21
1st Resistance Point 121.68
Last Price 120.94
1st Support Level 120.43
2nd Support Level 119.71
3rd Support Level 119.18

See More

52-Week High 141.23
Fibonacci 61.8% 130.64
Fibonacci 50% 127.36
Fibonacci 38.2% 124.09
Last Price 120.94
52-Week Low 113.50

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar